Copyright
©2012 Baishideng.
World J Nephrol. Oct 6, 2012; 1(5): 134-145
Published online Oct 6, 2012. doi: 10.5527/wjn.v1.i5.134
Published online Oct 6, 2012. doi: 10.5527/wjn.v1.i5.134
Source | Year | Kind of ACS | No. of patients | Evaluated mortality | CKD definition and severity | Mortality rate in CKD patients (%) | Mortality rate in no-CKD patients (%) | Comment |
Herzog et al[3] | 1998 | STEMI | 34 189 | In-hospital | Patients in dialysis | 26 | - | Included pts with a first STEMI after dialysis initiation |
1-yr | 59 | |||||||
2-yr | 73 | |||||||
3-yr | 81 | |||||||
5-yr | 90 | |||||||
10-yr | 97 | |||||||
Chertow et al[4] | 2000 | STEMI | 640 | 30-d (1-yr) | Patients in dialysis | 20 (53) | - | Only 7% of pts were treated with PCI and 5% with CABG |
McCullough et al[20] | 2000 | STEMI/NSTEMI | 9544 | Mean follow-up: 27.1 mo | CrCl > 81.5 mL/min | 30.5 | 14.6 | - |
81.5-63.1 mL/min | 54.5 | 22.7 | ||||||
63.1-46.2 mL/min | 65 | |||||||
< 46.2 mL/min | ||||||||
Dialysis | ||||||||
Beattie et al[5] | 2001 | STEMI | 1724 | In-hospital | CrCl > 81 mL/min | OR 3.88 | OR 1 | Age- and sex-adjusted risks for in-hospital death |
80-63 mL/min | OR 8.76 | OR 2.45 | ||||||
62-46 mL/min | OR 5.43 | |||||||
< 46 mL/min | ||||||||
HD | ||||||||
Wright et al[6] | 2002 | STEMI | 3106 | In-hospital | ClCl > 75 mL/min | 6 | 2 | - |
75-51 mL/min | 14 | |||||||
50-35 mL/min | 21 | |||||||
< 35 mL/min | 30 | |||||||
HD | ||||||||
Shlipak et al[7] | 2002 | STEMI | 130 099 | 1-yr | sCr < 1.5 mg/dL | 46 | 24 | Included pts with > 65 yr |
1.5-2.4 mg/dL | 66 | |||||||
2.5-3.9 mg/dL | ||||||||
Sorensen et al[22] | 2002 | STEMI | 6252 | 6-yr | CrCl > 85 mL/min | 62 | 22.5 | - |
85-71 mL/min | 83 | 32 | ||||||
70-56 mL/min | 46 | |||||||
55-41 mL/min | ||||||||
< 40 mL/min | ||||||||
Santopinto et al[8] | 2003 | STEMI | 4716 | In-hospital | CrCl > 60 mL/min | 8.1 | 2.1 | - |
30-60 mL/min | 18.1 | |||||||
< 30 mL/min | ||||||||
Santopinto et al[8] | 2003 | NSTEMI/UA | 7058 | In-hospital | CrCl > 60 mL/min | 3.8 | 0.9 | |
30-60 mL/min | 8.5 | |||||||
< 30 mL/min | ||||||||
Sadeghi et al[34] | 2003 | STEMI | 2082 | 30-d (1 yr) | CrCl < 60 mL/min | 7.5 (12.7) | 0.8 (7.5) | Primary PCI Excluded pts with sCr > 2 mg/dL or CS |
Hobbach et al[38] | 2003 | STEMI | 352 | 30-d (6-mo) | sCr > 1.2-2.8 mg/dL | 16 (19.5) | 3.4 (4.5) | Included pts treated with systemic thrombolysis |
Berger et al[43] | 2003 | STEMI | 146 765 | 30-d | Dialysis vs no dialysis patients | 29 | 18.3 (no dialysis) | Included pts with > 65 yr |
Freeman et al[61] | 2003 | STEMI/NSTEMI | 889 | In-hospital | sCr > 1.5 mg/dL | 8.1 | 2.6 | - |
Anavekar et al[23] | 2004 | STEMI | 14 527 | 3-yr | eGFR > 75 mL/min per 1.73 m2 | 28.9 | 14.1 | Included pts with HF and/or LV systolic dysfunction |
74.9-60 mL/min per 1.73 m2 | 45.5 | 20.5 | ||||||
59.9-45 mL/min per 1.73 m2 | ||||||||
< 45 mL/min per 1.73 m2 | ||||||||
Gibson et al[11] | 2004 | NSTEMI/UA | 13 307 | 30-d (6-mo) | eGFR > 90 mL/min per 1.73 m2 | 2.1 (3.8) | 1.3 (2.5) | - |
89-60 mL/min per 1.73 m2 | 5 (9.5) | |||||||
< 60 mL/min per 1.73 m2 | ||||||||
Masoudi et al[12] | 2004 | STEMI/NSTEMI/UA | 2706 | 7-mo | eGFR > 90 mL/min per 1.73 m2 | 15 | 3 | - |
89-60 mL/min per 1.73 m2 | 39 | 6 | ||||||
59-30 mL/min per 1.73 m2 | ||||||||
< 30 mL/min per 1.73 m2 | ||||||||
Mueller et al[29] | 2004 | NSTEMI/UA | 1400 | In-hospital (3-yr) | eGFR > 130 mL/min per 1.73 m2 | 5.1 (23.2) | 0 (7.4) | Included pts with PCI performed within 24 h |
129-90 mL/min per 1.73 m2 | 0.4 (4.5) | |||||||
89-60 mL/min per 1.73 m2 | 2.6 (8.1) | |||||||
< 60 mL/min per 1.73 m2 | ||||||||
Dumaine et al[66] | 2004 | ACS | 496 | In-hospital | CrCl < 60 mL/min | 4.8 | 0.9 | - |
Goldberg et al[73] | 2005 | STEMI | 1038 | In-hospital (1-yr) | eGFR > 90 mL/min per 1.73 m2 | 19.9 (29.9) | 4.7 (6.7) | - |
89-60 mL/min per 1.73 m2 | 6.3 (10) | |||||||
< 60 mL/min per 1.73 m2 | ||||||||
Han et al[74] | 2006 | NSTEMI/ UA | 45 343 | In-hospital | sCr > 2.0 mg/dL or dialysis | 9 | 3.6 | - |
Marenzi et al[40] | 2007 | STEMI | 467 | In-hospital | CrCl < 60 mL/min | 8.9 | 3.7 | Primary PCI |
Fox et al[57] | 2007 | STEMI | 20 479 | 30-d | CrCl > 90 mL/min | 15.30 | 2.6 | Thrombolysis Excluded pts with sCr > 2.5 (men) and > 2.0 (women) |
90-61 mL/min | 31.10 | 7.1 | ||||||
60-30 mL/min | ||||||||
< 30 mL/min | ||||||||
Pitsavos et al[75] | 2007 | STEMI/NSTEMI | 2172 | In-hospital | CrCl > 60 mL/min | 7 | 2 | - |
60-30 mL/min | 16 | |||||||
< 30 mL/min | ||||||||
Inrig et al[76] | 2008 | ACS | 9190 | 1-yr | eGFR > 90 mL/min per 1.73 m2 | 6 | 1.7 | - |
90-75 mL/min per 1.73 m2 | 5.7 | 2 | ||||||
75-60 mL/min per 1.73 m2 | 3.3 | |||||||
60-45 mL/min per 1.73 m2 | ||||||||
< 45 mL/min per 1.73 m2 | ||||||||
Szummer et al[30] | 2009 | NSTEMI | 23 262 | 1-yr | eGFR > 90 mL/min per 1.73 m2 | 16.7 | 5 | - |
89-60 mL/min per 1.73 m2 | 38.2 | 5.8 | ||||||
59-30 mL/min per 1.73 m2 | 51.2 | |||||||
29-15 mL/min per 1.73 m2 | ||||||||
< 15 mL/min per 1.73 m2/HD | ||||||||
Mehran et al[65] | 2009 | NSTEMI/UA | 12 939 | 30-d (1-yr) | CrCl < 60 mL/min | 3 (7.9) | 1.1 (2.8) | Excluded pts with CrCl < 30 mL/min |
James et al[50] | 2010 | STEMI/NSTEMI | 15 202 | 1-yr | CrCl < 60 mL/min | 12.1 | 3.3 | Included pts admitted < 24 h from symptoms onset |
Fox et al[15] | 2010 | STEMI | 19 089 | In-hospital | Stage 3a | 8.8 | 2.3 | - |
Stage 3b | 17.9 | |||||||
Stage 4 | 27.3 | |||||||
Stage 5 | 31.8 | |||||||
Fox et al[15] | 2010 | NSTEMI | 30 462 | In-hospital | Stage 3a | 4.8 | 1.8 | - |
Stage 3b | 8.6 | |||||||
Stage 4 | 13.4 | |||||||
Stage 5 | 12.4 | |||||||
Hachinohe et al[42] | 2011 | NSTEMI | 3615 | 1-yr | eGFR > 90 mL/min per 1.73 m2 | 9.4 | 4 | Excluded pts with CS |
89-60 mL/min per 1.73 m2 | 30 | 3 | ||||||
59-30 mL/min per 1.73 m2 | ||||||||
< 30 mL/min per 1.73 m2 | ||||||||
Hanna et al[77] | 2011 | NSTEMI | 40 074 | In-hospital | eGFR > 60 mL/min per 1.73 m2 | 2.8 | 0.6 | All pts were treated with PCI |
59-30 mL/min per 1.73 m2 | 6.1 | |||||||
29-15 mL/min per 1.73 m2 | 3.9 | |||||||
< 15 mL/min per 1.73 m2 |
- Citation: Marenzi G, Cabiati A, Assanelli E. Chronic kidney disease in acute coronary syndromes. World J Nephrol 2012; 1(5): 134-145
- URL: https://www.wjgnet.com/2220-6124/full/v1/i5/134.htm
- DOI: https://dx.doi.org/10.5527/wjn.v1.i5.134